144 related articles for article (PubMed ID: 27031502)
1. Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1α by Chemical Proteomics.
Okerberg ES; Hainley A; Brown H; Aban A; Alemayehu S; Shih A; Wu J; Patricelli MP; Kozarich JW; Nomanbhoy T; Rosenblum JS
PLoS One; 2016; 11(3):e0152934. PubMed ID: 27031502
[TBL] [Abstract][Full Text] [Related]
2. ERBB3 kinase domain mutations are rare in lung, breast and colon carcinomas.
Jeong EG; Soung YH; Lee JW; Lee SH; Nam SW; Lee JY; Yoo NJ; Lee SH
Int J Cancer; 2006 Dec; 119(12):2986-7. PubMed ID: 16998794
[No Abstract] [Full Text] [Related]
3. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth.
Feng X; Jia Y; Zhang Y; Ma F; Zhu Y; Hong X; Zhou Q; He R; Zhang H; Jin J; Piao D; Huang H; Li Q; Qiu X; Zhang Z
Autophagy; 2019 Jul; 15(7):1130-1149. PubMed ID: 30686098
[TBL] [Abstract][Full Text] [Related]
4. Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma.
Liu G; Li H; Zhang W; Yu J; Zhang X; Wu R; Niu M; Liu X; Yu R
J Cell Mol Med; 2021 Aug; 25(15):7395-7406. PubMed ID: 34216174
[TBL] [Abstract][Full Text] [Related]
5. Casein kinase 1α inhibits p53 downstream of MDM2‑mediated autophagy and apoptosis in acute myeloid leukemia.
Xu W; Huang Z; Gan Y; Chen R; Huang Y; Xue B; Jiang S; Yu Z; Yu K; Zhang S
Oncol Rep; 2020 Nov; 44(5):1895-1904. PubMed ID: 32901886
[TBL] [Abstract][Full Text] [Related]
6. Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia.
Järås M; Miller PG; Chu LP; Puram RV; Fink EC; Schneider RK; Al-Shahrour F; Peña P; Breyfogle LJ; Hartwell KA; McConkey ME; Cowley GS; Root DE; Kharas MG; Mullally A; Ebert BL
J Exp Med; 2014 Apr; 211(4):605-12. PubMed ID: 24616378
[TBL] [Abstract][Full Text] [Related]
7. Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location.
Cannon E; Buechler S
Clin Colorectal Cancer; 2019 Jun; 18(2):149-158. PubMed ID: 30853326
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived CK1α mutations enhance MDMX inhibition of p53.
Liu X; Huang Q; Chen L; Zhang H; Schonbrunn E; Chen J
Oncogene; 2020 Jan; 39(1):176-186. PubMed ID: 31462704
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice.
Ma Z; Zheng H; Li X; Yu B; Peng H
Theriogenology; 2023 Mar; 198():30-35. PubMed ID: 36542875
[TBL] [Abstract][Full Text] [Related]
10. Calotropin: a cardenolide from calotropis gigantea that inhibits Wnt signaling by increasing casein kinase 1α in colon cancer cells.
Park HY; Toume K; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
Chembiochem; 2014 Apr; 15(6):872-8. PubMed ID: 24644251
[TBL] [Abstract][Full Text] [Related]
11. CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysis.
Smith AE; Kulasekararaj AG; Jiang J; Mian S; Mohamedali A; Gaken J; Ireland R; Czepulkowski B; Best S; Mufti GJ
Lancet Haematol; 2015 May; 2(5):e212-21. PubMed ID: 26688096
[TBL] [Abstract][Full Text] [Related]
12. A screen for X-linked mutations affecting Drosophila photoreceptor differentiation identifies Casein kinase 1α as an essential negative regulator of wingless signaling.
Legent K; Steinhauer J; Richard M; Treisman JE
Genetics; 2012 Feb; 190(2):601-16. PubMed ID: 22095083
[TBL] [Abstract][Full Text] [Related]
13. Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics.
Mu Y; Chen Y; Zhang G; Zhan X; Li Y; Liu T; Li G; Li M; Xiao Z; Gong X; Chen Z
Electrophoresis; 2013 Jun; 34(11):1679-92. PubMed ID: 23737015
[TBL] [Abstract][Full Text] [Related]
14. Site-specific Differences in Colonic Adenocarcinoma: KRAS Mutations and High Tumor Budding Are More Frequent in Cecal Adenocarcinoma.
Landau MA; Zhu B; Akwuole FN; Pai RK
Am J Surg Pathol; 2018 Mar; 42(3):351-358. PubMed ID: 29240583
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of keratin cytoskeleton organization through casein kinase Iα and FAM83H in colorectal cancer.
Kuga T; Kume H; Kawasaki N; Sato M; Adachi J; Shiromizu T; Hoshino I; Nishimori T; Matsubara H; Tomonaga T
J Cell Sci; 2013 Oct; 126(Pt 20):4721-31. PubMed ID: 23902688
[TBL] [Abstract][Full Text] [Related]
16. Src activation regulates anoikis in human colon tumor cell lines.
Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
[TBL] [Abstract][Full Text] [Related]
17. MiniSOX9, a dominant-negative variant in colon cancer cells.
Abdel-Samad R; Zalzali H; Rammah C; Giraud J; Naudin C; Dupasquier S; Poulat F; Boizet-Bonhoure B; Lumbroso S; Mouzat K; Bonnans C; Pignodel C; Raynaud P; Fort P; Quittau-Prévostel C; Blache P
Oncogene; 2011 Jun; 30(22):2493-503. PubMed ID: 21297661
[TBL] [Abstract][Full Text] [Related]
18. Structural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1α and PKR.
Sudha G; Yamunadevi S; Tyagi N; Das S; Srinivasan N
BMC Struct Biol; 2012 Nov; 12():28. PubMed ID: 23148689
[TBL] [Abstract][Full Text] [Related]
19. Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression.
Glover SC; Tretiakova MS; Carroll RE; Benya RV
Mol Carcinog; 2003 May; 37(1):5-15. PubMed ID: 12720295
[TBL] [Abstract][Full Text] [Related]
20. Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt/beta-catenin independent mechanism.
Tsai IC; Woolf M; Neklason DW; Branford WW; Yost HJ; Burt RW; Virshup DM
Int J Cancer; 2007 Mar; 120(5):1005-12. PubMed ID: 17131344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
